EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   3.4.21.61 | Abetalipoproteinemia |
24751931 |
Hypobetalipoproteinemia and abetalipoproteinemia. |
causal interaction
unassigned |
2
0 |
| 3.4.21.61 | Abetalipoproteinemia |
27179706 |
Identification of novel APOB mutations by targeted next-generation sequencing for the molecular diagnosis of familial hypobetalipoproteinemia. |
ongoing research
therapeutic application
unassigned |
2
1
0 |
| 3.4.21.61 | Abetalipoproteinemia |
32039990 |
Hypobetalipoproteinemia and abetalipoproteinemia: liver disease and cardiovascular disease. |
unassigned |
0 |
| 3.4.21.61 | Acquired Immunodeficiency Syndrome |
21372726 |
Serologic responses to Pneumocystis Proteins in Human Immunodeficiency Virus Patients With and Without Pneumocystis jirovecii Pneumonia. |
ongoing research
therapeutic application
unassigned |
4
1
0 |
| 3.4.21.61 | ACTH-Secreting Pituitary Adenoma |
14558669 |
Significance of absent prohormone convertase 1/3 in inducing clinically silent corticotroph pituitary adenoma of subtype I--immunohistochemical study. |
causal interaction
diagnostic usage
ongoing research
unassigned |
1
3
2
0 |
| 3.4.21.61 | ACTH-Secreting Pituitary Adenoma |
17410413 |
Immunohistochemical properties of silent corticotroph adenoma and Cushing's disease. |
diagnostic usage
ongoing research
unassigned |
3
3
0 |
| 3.4.21.61 | ACTH-Secreting Pituitary Adenoma |
17917309 |
Defective expression of prohormone convertase 1/3 in silent corticotroph adenoma. |
unassigned |
0 |
| 3.4.21.61 | ACTH-Secreting Pituitary Adenoma |
20501680 |
Possible relevance between prohormone convertase 2 expression and tumor growth in human adrenocorticotropin-producing pituitary adenoma. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
3
3
1 |
| 3.4.21.61 | Acute Coronary Syndrome |
25440796 |
Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: rationale and design of the ODYSSEY outcomes trial. |
ongoing research
unassigned |
4
0 |
| 3.4.21.61 | Acute Coronary Syndrome |
25814425 |
A Review of the Key Clinical Trials of 2014. |
causal interaction
therapeutic application
unassigned |
3
4
0 |
